PRESS RELEASES

Press Release

Altasciences Receives 2023 CRO Leadership Award for Capabilities

May 4, 2023

Altasciences has been recognized for excellence in contract research with a 2023 CRO Leadership Award for Capabilities. This marks the eighth year that Altasciences, a fully integrated drug development solution company, has been deemed a top performer.

Press Release

Altasciences Completes Clinical Portion of Alzamend Neuro's Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer's

Apr 18, 2023

Press Release

Altasciences Receives Accreditation From College of American Pathologists

Oct 31, 2022

Press Release

Altasciences Expands Laboratory Capabilities in Columbia

Oct 17, 2022

Press Release

Altasciences Expands Strategic Support for Early Drug Development in Europe and Adds Key Employees to Its Preclinical Team in North America

Oct 13, 2022

Press Release

Hoth Therapeutics Announces the Selection of Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke

Sep 20, 2022

Press Release

Altasciences Receives 2022 CRO Leadership Award in Five Categories

May 2, 2022

Press Release

Alzamend Neuro Contracts with Altasciences and iResearch Atlanta to Manage and Conduct Its Phase IIA Study in Patients with Alzheimer’s

Apr 13, 2022

This is Alzamend Neuro's second study with Altasciences for the same program.

Press Release

Dr. Wendell P. Davis Joins Altasciences as Vice President, Pathology

Feb 7, 2022

Press Release

Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee

Jan 21, 2022